In the matched analysis, each GLP-1 user was paired with a non-user who had similar characteristics, including age, race, ethnicity, BMI, breast density, and diabetes status
Ozempic was approved for type 2 diabetes in 2017, but its origins at Novo Nordisk stretch back nearly a decade earlier
The FDA has announced release of an additional 89 previously unpublished complete response letters (CRLs) or rejection letters associated with pending or withdrawn applications
Medicare Part D coverage expansion represents a USD 18.4 billion addressable GLP-1 market catalyst that could restructure U.S
Answer a few quick questions about your symptoms and goals
In case a serious adverse event would require the randomization code to be broken for a given participant, sealed opaque envelopes labelled with the randomization number and containing the associated supplements were prepared by the same unblinded individual, and kept at the clinical center